Literature DB >> 1499105

Superoxide dismutase enhances ischemia-induced reactive hyperemic flow and adenosine release in dogs. A role of 5'-nucleotidase activity.

M Kitakaze1, M Hori, S Takashima, K Iwai, H Sato, M Inoue, A Kitabatake, T Kamada.   

Abstract

To test the hypothesis that 5'-nucleotidase activity during ischemia is attenuated by oxygen-derived free radicals, we measured ischemia-induced reactive hyperemic flow, adenosine release, and 5'-nucleotidase activity in dogs (n = 62). A 1-minute occlusion of the coronary artery caused reactive hyperemic flow (307 +/- 5 versus 92 +/- 1 ml.100 g-1.min-1 at baseline) with increased release of adenosine (14.4 +/- 1.4 versus 0.4 +/- 0.1 nmol.100 g-1.min-1 at baseline). Superoxide dismutase augmented (p less than 0.001) both peak coronary blood flow (333 +/- 6 ml.100 g-1.min-1) and repayment (436 +/- 12 versus 320 +/- 7 ml/100 g in the untreated group). Adenosine release during reperfusion was augmented (22.7 +/- 1.9 nmol.100 g-1.min-1, p less than 0.001), and 8-phenyltheophylline completely abolished the enhanced reactive hyperemia. Enzymatic assay of 5'-nucleotidase activity revealed that the administration of superoxide dismutase increases ecto-5'-nucleotidase activity in ischemic myocardium. When an inhibitor of ecto-5'-nucleotidase, alpha, beta-methyleneadenosine 5'-diphosphate, was administered, the effects of superoxide dismutase were completely abolished. Thus, we conclude that 1) the augmentation of reactive hyperemic flow caused by superoxide dismutase is attributed to the enhanced release of adenosine and 2) the enhanced release of adenosine over the untreated controls is attributed to the protection of ecto-5'-nucleotidase activity during ischemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499105     DOI: 10.1161/01.res.71.3.558

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Effect of superoxide dismutase on acute reperfusion injury of the rabbit brain.

Authors:  E Tasdemiroglu; P D Chistenberry; J L Ardell; R B Chronister; A E Taylor
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 2.  It is time to ask what adenosine can do for cardioprotection.

Authors:  M Kitakaze; M Hori
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

3.  Enhancement of coronary reactive hyperemia in patients with ischemic myocardial tolerance during angioplasty.

Authors:  T Tanaka; H Nonogi; S Miyazaki; Y Goto; A Itoh; S Daikoku; Y Yamamoto
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

4.  Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A2A receptor and plasma oxylipins.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; John R Falck; Catherine Ledent; Stephen L Tilley; Mohammed A Nayeem
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-09-07       Impact factor: 3.072

5.  Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; Mohammed A Nayeem
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

6.  Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; John R Falck; Mohammed A Nayeem
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

7.  Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; John R Falck; Mohammed A Nayeem
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.